Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

New program aims to boost HIV med adherence and mental health for MSM in south africa

NCT ID NCT06880172

Disease control Sponsor: Emory University Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This completed study tested a behavioral program called WeCare for men who have sex with men (MSM) in South Africa. The program included individual sessions to identify problems and create action plans, plus group sessions for social support and coping with stigma. The goal was to improve mental health and help participants stick to their HIV medication (ART or PrEP). Only 12 men took part, so the results are very preliminary.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
WeCare behavioral program
What this could lead to
If successful, this program could offer a practical way to support mental health and medication adherence for men who have sex with men living with or at risk for HIV.
What could go wrong
This was a very small pilot study with only 12 participants, so results may not apply to larger groups. The program requires group sessions, which may not work for everyone.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

12 people

The number who actually took part.

Started

May 2025

Finished

Jul 2025

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 years and older

Sex

Male participants only

Healthy volunteers

Accepted

You do not need to have the condition being studied to take part.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Cis-gender male * Reside in the Johannesburg metropolitan area with no plans to relocate during the next 6 months * Current prescription for any ART regimen (HIV-positive participants) or daily oral PrEP (HIV-negative participants) at the POP INN clinic * Self-reported challenges adhering to daily ART (HIV-positive participants) or PrEP (HIV-negative participants) * Interested in participating in a group discussion to discuss common mental health problems and medication adherence challenges * Ability to understand and provide informed consent. Exclusion Criteria: * Presently engaged in mental health therapy. * Participated as an intervention participant in a pilot mental health study (AUR6-8-403) * Refuses audio recording of the focus group discussion * Those who score over 20 on the PHQ-9 (i.e., indicating severe depression)

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for HIV are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

HIV infectious disease

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

HIV

Contacts and locations

Locations

  • The Aurum Institute

    Johannesburg, 2194, South Africa

More trials for these conditions

Other studies related to the condition(s) this trial covers.